SWA
IMUX icon

Strategies Wealth Advisors’s Immunic IMUX Stock Holding History

Strategies Wealth Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$111K Hold
10,000
– – 0.01% 188
2025
Q4 		$53.4K Hold
10,000
– – 0.01% 184
2025
Q3 		$88.2K Hold
10,000
– – 0.01% 183
2025
Q2 		$69.8K Buy
+10,000
New +$91.8K 0.01% 182

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Strategies Wealth Advisors's IMUX Position: Q1 2026 in Review

Strategies Wealth Advisors held its Immunic (IMUX) position steady in Q1 2026 at 10,000 shares worth $111K. The position accounts for 0.01% of the portfolio, ranked #188.

Strategies Wealth Advisors first reported a position in IMUX in Q2 2025 and has held it in 4 quarters since. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Strategies Wealth Advisors held 10,000 shares of Immunic worth $111K as of Q1 2026.
  • Strategies Wealth Advisors left its Immunic share count unchanged in Q1 2026.
  • Immunic made up 0.01% of Strategies Wealth Advisors's portfolio in Q1 2026, its #188 holding.
  • Strategies Wealth Advisors first reported a position in Immunic in Q2 2025 and has held it in 4 quarters since.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Strategies Wealth Advisors's 13F filing for Q1 2026, filed 15 May 2026.